Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

AcroMeta Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

AcroMeta Group şirketinin toplam hissedar öz sermayesi SGD1.7M ve toplam borcu SGD5.8M olup, bu da borç-öz sermaye oranını 346% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SGD31.8M ve SGD30.1M dir.

Anahtar bilgiler

346.0%

Borç/özkaynak oranı

S$5.81m

Borç

Faiz karşılama oranı	n/a
Nakit	S$4.94m
Eşitlik	S$1.68m
Toplam yükümlülükler	S$30.14m
Toplam varlıklar	S$31.82m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 43F 'nin kısa vadeli varlıkları ( SGD23.5M ) kısa vadeli yükümlülüklerini ( SGD26.3M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: 43F şirketinin kısa vadeli varlıkları ( SGD23.5M ) uzun vadeli yükümlülüklerini ( SGD3.8M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 43F 'nin net borç/öz sermaye oranı ( 51.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 43F şirketinin borç/öz sermaye oranı son 5 yılda 42.4% seviyesinden 346% seviyesine yükseldi.

Borç Kapsamı: 43F 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 43F şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

AcroMeta Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Anton Setiawan acquired 67% stake in PT Acromec Trading Indonesia from AcroMeta Group Limited (Catalist:43F) for SGD 5000.

Executive Director recently bought S$53k worth of stock

High number of new and inexperienced directors

Acrometa Group Limited Appoints Toh Ker How as the Executive Director of the Company

An undisclosed buyer agreed to acquire 70% stake in Life Science Incubator Pte Ltd from AcroMeta Group Limited (Catalist:43F).

First half 2024 earnings released: S$0.007 loss per share (vs S$0.004 profit in 1H 2023)

AcroMeta Group Limited Announces Re-Designation of Lim Say Chin as Executive Director to Executive Chairman

Acrometa Group Limited Announces Resignation of Levin Lee Keng Weng as Executive Chairman

High number of new and inexperienced directors

AcroMeta Group Limited Announces Retirement of Chew Chee Keong as Executive Director, Effective 30 January 2024

Full year 2023 earnings released: EPS: S$0.036 (vs S$0.028 in FY 2022)

AcroMeta Group Limited, Annual General Meeting, Jan 30, 2024

Full year 2023 earnings released: EPS: S$0.033 (vs S$0.012 in FY 2022)

New minor risk - Financial data availability

AcroMeta Group Limited has filed a Follow-on Equity Offering in the amount of SGD 0.5 million.

AcroMeta Group Limited has filed a Follow-on Equity Offering in the amount of SGD 0.5 million.

Acrometa Group Limited Appoints Cheah Lai Min as Chief Financial Officer

New minor risk - Share price stability

Acrometa Group Limited Announces Resignation of Tan Buck Kiang Jerry as Chief Financial Officer

AcroMeta Group Limited (Catalist:43F) completed the acquisition of additional 40% stake in Life Science Incubator Pte Ltd.

First half 2023 earnings released: EPS: S$0.004 (vs S$0.001 in 1H 2022)

Executive Chairman recently sold S$126k worth of stock

AcroMeta Group Limited (Catalist:43F) entered into a legally binding letter of intent to acquire additional 40% stake in Life Science Incubator Pte Ltd for SGD 1.6 million.

Acrometa Group Limited Appoints Cheong Keng Chuan, Alfred as Non-Executive and Lead Independent Director, Audit Committee Chairman and Member of the Nominating Committee and Remuneration Committee

Non-Executive Non-Independent Director recently sold S$56k worth of stock

Less than half of directors are independent

AcroMeta Group Limited Appoints Levin Lee Keng Weng as Executive Chairman and Director of the Board

AcroMeta Group Limited, Annual General Meeting, Jan 30, 2023

Acrometa Group Limited Announces Appointment of Mahtani Bhagwandas an Independent Director

Full year 2022 earnings released: EPS: S$0.012 (vs S$0.001 in FY 2021)

AcroMeta Group Limited Group Limited Announces Resignation of Elaine Beh Pur-Lin as Independent Director

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Acromec Limited Appoints John Geno-Oehlers as Independent Director, Member of the Audit, Remuneration and Nominating Committees

Acromec Limited Announces Expiry of Memorandum of Understanding

Full year 2020 earnings released: S$0.011 loss per share

Acromec Limited, Annual General Meeting, Jan 27, 2021

Acromec Limited to Report Fiscal Year 2020 Results on Nov 27, 2020

Acromec Limited (Catalist:43F) completed the acquisition of remaining 40% stake in Golden Harvest Engineering Pte Ltd from Liang Kum Keong and Quek Ghee Leong.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin